Otolith Labs

About Otolith Labs

Otolith Labs develops a noninvasive wearable device utilizing patented Vestibular Resonance Therapy (nVRT) technology to treat chronic vertigo, affecting over 11 million Americans. The device requires no surgery or complex fittings, providing a safe and effective alternative to traditional treatments.

```xml <problem> Chronic vertigo affects millions, significantly impacting their quality of life. Traditional treatments often involve surgery or complex fittings, presenting challenges for many patients seeking relief. </problem> <solution> Otolith Labs is developing a non-invasive wearable device that utilizes patented Vestibular Resonance Therapy (nVRT) to treat chronic vertigo. The headworn device is designed to be easy to use, requiring no surgery, advanced patient calibration, or complex fittings. Through clinical studies, the device has been tested on hundreds of subjects and is designed to be safe. The device aims to provide a safe and effective alternative for individuals seeking relief from chronic vertigo symptoms. </solution> <features> - Non-invasive Vestibular Resonance Therapy (nVRT) technology - Compact, headworn wearable design - No surgery, advanced patient calibration, or complex fittings required - Designed for safety, with testing on over 600 subjects - Intended to manage the symptoms of vertigo </features> <target_audience> The primary target audience includes individuals suffering from chronic vertigo, as well as healthcare providers seeking non-invasive treatment options for their patients. </target_audience> ```

What does Otolith Labs do?

Otolith Labs develops a noninvasive wearable device utilizing patented Vestibular Resonance Therapy (nVRT) technology to treat chronic vertigo, affecting over 11 million Americans. The device requires no surgery or complex fittings, providing a safe and effective alternative to traditional treatments.

Where is Otolith Labs located?

Otolith Labs is based in Newcastle West, Australia.

When was Otolith Labs founded?

Otolith Labs was founded in 2022.

How much funding has Otolith Labs raised?

Otolith Labs has raised 34730000.

Location
Newcastle West, Australia
Founded
2022
Funding
34730000
Employees
21 employees
Major Investors
Morningside Venture Partners

Find Investable Startups and Competitors

Search thousands of startups using natural language

Otolith Labs

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Otolith Labs develops a noninvasive wearable device utilizing patented Vestibular Resonance Therapy (nVRT) technology to treat chronic vertigo, affecting over 11 million Americans. The device requires no surgery or complex fittings, providing a safe and effective alternative to traditional treatments.

otolithlabs.com1K+
cb
Crunchbase
Founded 2022Newcastle West, Australia

Funding

$

Estimated Funding

$20M+

Major Investors

Morningside Venture Partners

Team (20+)

No team information available.

Company Description

Problem

Chronic vertigo affects millions, significantly impacting their quality of life. Traditional treatments often involve surgery or complex fittings, presenting challenges for many patients seeking relief.

Solution

Otolith Labs is developing a non-invasive wearable device that utilizes patented Vestibular Resonance Therapy (nVRT) to treat chronic vertigo. The headworn device is designed to be easy to use, requiring no surgery, advanced patient calibration, or complex fittings. Through clinical studies, the device has been tested on hundreds of subjects and is designed to be safe. The device aims to provide a safe and effective alternative for individuals seeking relief from chronic vertigo symptoms.

Features

Non-invasive Vestibular Resonance Therapy (nVRT) technology

Compact, headworn wearable design

No surgery, advanced patient calibration, or complex fittings required

Designed for safety, with testing on over 600 subjects

Intended to manage the symptoms of vertigo

Target Audience

The primary target audience includes individuals suffering from chronic vertigo, as well as healthcare providers seeking non-invasive treatment options for their patients.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.